Patents by Inventor Pankaj Ramanbhai Patel

Pankaj Ramanbhai Patel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT FOR LIPODYSTROPHY
    Publication number: 20190100492
    Abstract: The present invention provides a therapeutic compound of formula (I) and their pharmaceutically acceptable salts for the prevention and treatment of lipodystrophy caused because of HIV infection or combination therapy of HIV-1 protease inhibitors (PIs) and/or reverse transcriptase inhibitors (nRTIs) by neutralizing lipohypertrophy, lipoatrophy and metabolic abnormalities in HIV patient.
    Type: Application
    Filed: May 30, 2018
    Publication date: April 4, 2019
    Inventors: Dhiraj Gambhire, Rajendrakumar Hariprasad Jani, Bipin Pandey, Kaushik Sata, Himanshu Kothari, Pankaj Ramanbhai Patel
  • Treatment for lipodystrophy
    Patent number: 10017470
    Abstract: The present invention provides a therapeutic compound of formula (I) and their pharmaceutically acceptable salts for the prevention and treatment of lipodystrophy caused because of HIV infection or combination therapy of HIV-1 protease inhibitors (Pis) and/or reverse transcriptase inhibitors (nRTIs) by neutralizing lipohypertrophy, lipoatrophy and metabolic abnormalities in HIV patient.
    Type: Grant
    Filed: January 30, 2012
    Date of Patent: July 10, 2018
    Assignee: Cadila Healthcare Limited
    Inventors: Dhiraj Gambhire, Rajendrakumar Hariprasad Jani, Bipin Pandey, Kaushik Sata, Himanshu Kothari, Pankaj Ramanbhai Patel
  • TREATMENT FOR LIPODYSTROPHY
    Publication number: 20170088514
    Abstract: The present invention provides a therapeutic compound of formula (I) and their pharmaceutically acceptable salts for the prevention and treatment of lipodystrophy caused because of HIV infection or combination therapy of HIV-1 protease inhibitors (PIs) and/or reverse transcriptase inhibitors (nRTIs) by neutralizing lipohypertrophy, lipoatrophy and metabolic abnormalities in HIV patient.
    Type: Application
    Filed: November 7, 2016
    Publication date: March 30, 2017
    Inventors: Dhiraj Gambhire, Rajendrakumar Hariprasad Jani, Bipin Pandey, Kaushik Sata, Himanshu Kothari, Pankaj Ramanbhai Patel
  • Pharmaceutical compositions of lurasidone
    Patent number: 9433620
    Abstract: The present invention relates to pharmaceutical compositions of lurasidone or salts thereof. In particular, the invention relates to pharmaceutical compositions of lurasidone or salts thereof with one or more water-insoluble pharmaceutical excipients. The invention also relates to processes for the preparation of such compositions and use thereof for treatment of schizophrenia, bipolar disorders or senile dementia.
    Type: Grant
    Filed: January 5, 2012
    Date of Patent: September 6, 2016
    Assignee: CADILA HEALTHCARE LIMITED
    Inventors: Brij Khera, Aman Trehan, Pankaj Ramanbhai Patel
  • Quinolone derivatives
    Patent number: 9394300
    Abstract: The present invention relates to novel compounds of the general formula (I), their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods for their preparation, use of these compounds in medicine and the intermediates involved in their preparation.
    Type: Grant
    Filed: December 23, 2013
    Date of Patent: July 19, 2016
    Assignee: Cadila Healthcare Limited
    Inventors: Ranjit C. Desai, Vrajesh Pandya, Pankaj Ramanbhai Patel
  • NOVEL QUINOLONE DERIVATIVES
    Publication number: 20150299193
    Abstract: The present invention relates to novel compounds of the general formula (I), their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods for their preparation, use of these compounds in medicine and the intermediates involved in their preparation.
    Type: Application
    Filed: December 23, 2013
    Publication date: October 22, 2015
    Applicant: Cadila Healthcare Limited
    Inventors: Ranjit C. Desai, Vrajesh Pandya, Pankaj Ramanbhai Patel
  • PHARMACEUTICAL COMPOSITIONS OF LURASIDONE
    Publication number: 20140348909
    Abstract: The present invention relates to pharmaceutical compositions of lurasidone or salts thereof. In particular, the invention relates to pharmaceutical compositions of lurasidone or salts thereof with one or more water-insoluble pharmaceutical excipients. The invention also relates to processes for the preparation of such compositions and use thereof for treatment of schizophrenia, bipolar disorders or senile dementia.
    Type: Application
    Filed: January 5, 2012
    Publication date: November 27, 2014
    Applicant: Cadila Healthcare limited
    Inventors: Brij Khera, Aman Trehan, Pankaj Ramanbhai Patel
  • Peptidomimetics with glucagon antagonistic and GLP 1 agonistic activities
    Patent number: 8883963
    Abstract: The present invention provides novel peptidomimetics, of formula (I), which primarily act as glucose dependent insulin secretagogues. Furthermore, it was found that these peptidomimetics showed glucagon receptor antagonistic activity, along with the GLP-I receptor agonistic activity.
    Type: Grant
    Filed: December 10, 2008
    Date of Patent: November 11, 2014
    Assignee: Cadila Healthcare Limited
    Inventors: Rajesh H. Bahekar, Mukul R. Jain, Pankaj Ramanbhai Patel
  • Antidiabetic compounds
    Patent number: 8841413
    Abstract: The present invention provides novel peptidomimetics, of formula (I), which primarily act as glucose dependent insulin secretagogues. Furthermore, it was found that these peptidomimetics showed glucagon receptor antagonistic activity, along with the GLP-1 receptor agonistic activity.
    Type: Grant
    Filed: September 28, 2007
    Date of Patent: September 23, 2014
    Assignee: Cadila Healthcare Limited
    Inventors: Rajesh H. Bahekar, Braj Bhushan Lohray, Vidya Bhushan Lohray, Mukul R. Jain, Kaushik M. Banerjee, Pankaj Ramanbhai Patel
  • TREATMENT FOR LIPODYSTROPHY
    Publication number: 20130338209
    Abstract: The present invention provides a therapeutic compound of formula (I) and their pharmaceutically acceptable salts for the prevention and treatment of lipodystrophy caused because of HIV infection or combination therapy of HIV-1 protease inhibitors (Pis) and/or reverse transcriptase inhibitors (nRTIs) by neutralizing lipohypertrophy, lipoatrophy and metabolic abnormalities in HIV patient.
    Type: Application
    Filed: January 30, 2012
    Publication date: December 19, 2013
    Applicant: CADILA HEALTHCARE LIMITED
    Inventors: Dhiraj Gambhire, Rajendrakumar Hariprasad Jani, Bipin Pandey, Kaushik Sata, Himanshu Kothari, Pankaj Ramanbhai Patel
  • Antidiabetic Comppounds
    Publication number: 20130225488
    Abstract: The present invention provides novel peptidomimetics, of formula (I), which primarily act as glucose dependent insulin secretagogues. Furthermore, it was found that these peptidomimetics showed glucagon receptor antagonistic activity, along with the GLP-1 receptor agonistic activity.
    Type: Application
    Filed: September 28, 2007
    Publication date: August 29, 2013
    Inventors: Rajesh H. Bahekar, Braj Bhushan Lohray, Vidya Bhushan Lohray, Mukul R. Jain, Kaushik M. Banerjee, Pankaj Ramanbhai Patel
  • Formulations of PEG-interferon alpha conjugates
    Patent number: 8367054
    Abstract: Lyophilized and stabilized formulations of PEG-Interferon alpha conjugates and the process for their preparation that reduces lyophilization cycle time and are more cost competitive.
    Type: Grant
    Filed: November 16, 2007
    Date of Patent: February 5, 2013
    Assignee: Cadila Healthcare Limited
    Inventors: Sanjay Bandyopadhyay, Venkatesan Natarajan, Sanjeev Kumar Mendiratta, Pankaj Ramanbhai Patel
  • Adaptation of Pitman Moore strain of rabies virus to primary chick embryo fibroblast cell cultures
    Patent number: 8361776
    Abstract: The present invention relates to a process of adaptation of Pitman Moore strain of rabies virus to Primary chick fibroblast cells for the production of rabies vaccine.
    Type: Grant
    Filed: April 24, 2008
    Date of Patent: January 29, 2013
    Assignee: Cadila Healthcare Limited
    Inventors: Pradip Maganlal Patel, Pankaj Ramanbhai Patel
  • 1,3-dioxane carboxylic acids
    Patent number: 8268867
    Abstract: The present invention relates to novel 1,3-dioxane carboxylic acids of the general formula (I), their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods for their preparation, use of these compounds in medicine and the intermediates involved in their preparation.
    Type: Grant
    Filed: February 19, 2007
    Date of Patent: September 18, 2012
    Assignee: Cadila Healthcare Limited
    Inventors: Harikishore Pingali, Pankaj Maganlal Makadia, Braj Bhushan Lohray, Vidya Bhushan Lohray, Pankaj Ramanbhai Patel
  • Sulfoxamine derivatives as factor Xa inhibitors
    Patent number: 8227492
    Abstract: The present invention relates to novel substituted sulfoximine derivatives of the general formula (I), their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods for their preparation, use of these compounds in medicine and the intermediates involved in their preparation.
    Type: Grant
    Filed: August 4, 2008
    Date of Patent: July 24, 2012
    Assignee: Cadila Healthcare Limited
    Inventors: Vrajesh B. Pandya, Pankaj Ramanbhai Patel
  • PEPTIDOMIMETICS WITH GLUCAGON ANTAGONISTIC AND GLP 1 AGONISTIC ACTIVITIES
    Publication number: 20120021972
    Abstract: The present invention provides novel peptidomimetics, of formula (I), which primarily act as glucose dependent insulin secretagogues. Furthermore, it was found that these peptidomimetics showed glucagon receptor antagonistic activity, along with the GLP-I receptor agonistic activity.
    Type: Application
    Filed: December 10, 2008
    Publication date: January 26, 2012
    Inventors: Rajesh H. Bahekar, Mukul R. Jain, Pankaj Ramanbhai Patel
  • Process for preparing (S)-(+)-clopidogrel base and its salts
    Patent number: 7960550
    Abstract: Processes for the preparation of Methyl (+)-(S)-(2-chlorophenyl)-(6,7dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate [Clopidogrel base, (I)] and their various pharmaceutically acceptable salts.
    Type: Grant
    Filed: January 8, 2007
    Date of Patent: June 14, 2011
    Assignee: Cadila Healthcare Limited
    Inventors: Parind Narendra Dholakia, Mayank Ghanshyambhai Dave, Pankaj Ramanbhai Patel
  • SULFOXIMINE DERIVATIVES AS FACTOR XA INHIBITORS
    Publication number: 20110065717
    Abstract: The present invention relates to novel substituted sulfoximine derivatives of the general formula (I), their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods for their preparation, use of these compounds in medicine and the intermediates involved in their preparation.
    Type: Application
    Filed: August 4, 2008
    Publication date: March 17, 2011
    Applicant: CADILA HEALTHCARE LIMITED
    Inventors: Vrajesh B. Pandya, Pankaj Ramanbhai Patel
  • PROCESS FOR PREPARING CHEMICALLY AND CHIRALLY PURE SOLIFENACIN BASE AND ITS SALTS
    Publication number: 20100298371
    Abstract: The present invention provides improved processes for preparing chemically and chirally pure Solifenacin base. The present invention also provides for a composition comprising of a salt of Solifenacin having at least 98% purity. The present invention also disclose certain new salts of Solifenacin as well as well as new polymorphic forms of Solifenacin hydrochloride and Solifenacin oxalate, in pure form.
    Type: Application
    Filed: December 2, 2008
    Publication date: November 25, 2010
    Inventors: Mayank Ghanshyambhai Dave, Bipin Pandey, Himanshu M. Kothari, Pankaj Ramanbhai Patel
  • RENIN INHIBITORS
    Publication number: 20100280024
    Abstract: The present invention relates to renin inhibitors of formula (I), their pharmaceutically acceptable salts and pharmaceutical compositions containing them. The present invention also relates to a process of preparing compounds of general formula (I), their tautomeric forms, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, and novel intermediates involved in their synthesis.
    Type: Application
    Filed: October 13, 2008
    Publication date: November 4, 2010
    Inventors: Jigar Desai, Pravin S. Thombare, Mukul R. Jain, Pankaj Ramanbhai Patel